Latest market price
10.89
+0.00%
OverviewShort InterestFilings
DMAAQT40Drugs Made In America Acquisition Corp. Ordinary Shares·NASDAQ
10.89+0.00%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 21, 20268-KCurrent report
Oct 21, 2026425Prospectus / business-combination communication
Sep 14, 2026425Prospectus / business-combination communication
Sep 14, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 202610-QQuarterly report
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 20, 20268-KCurrent report
Jul 20, 2026425Prospectus / business-combination communication
Jun 26, 2026SC 13GBeneficial ownership statement (passive)
May 14, 2026SC 13GBeneficial ownership statement (passive)
May 14, 202610-QQuarterly report
May 05, 2026425Prospectus / business-combination communication
May 05, 20268-KCurrent report
May 01, 20268-KCurrent report
Apr 28, 20268-KCurrent report
Apr 16, 2026DEFR14ADEFR14A
Apr 15, 202610-KAnnual report
Apr 14, 2026DEF 14ADefinitive proxy statement
Apr 08, 20268-KCurrent report
Apr 01, 2026NT 10-KNT 10-K
Mar 27, 2026PRE 14APreliminary proxy statement
Mar 27, 20268-KCurrent report
#1 / 25 of 80
Page
▼
/ 4